or Try an Advanced Search...

    Technical Analysis for DTIL - Precision BioSciences, Inc.

    Grade Last Price % Change Price Change
    D 9.89 1.64% 0.16
    DTIL closed up 1.64 percent on Monday, July 1, 2024, on 1.5 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical DTIL trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion 1.64%
    Oversold Stochastic Weakness 1.64%
    Wide Bands Range Expansion 4.99%
    Oversold Stochastic Weakness 4.99%
    NR7 Range Contraction 2.28%
    NR7-2 Range Contraction 2.28%
    Narrow Range Bar Range Contraction 2.28%
    Wide Bands Range Expansion 2.28%
    Older End-of-Day Signals for DTIL ...

       Recent Intraday Alerts

    Alert Time
    Up 2% about 7 hours ago
    Up 1% about 7 hours ago
    Rose Above Previous Day's High about 8 hours ago
    10 DMA Resistance about 8 hours ago
    2x Volume Pace about 8 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    DTIL Chart by TradingView
    Basic chart:

    Profile

    Precision BioSciences is dedicated to improving life (DTIL) through its proprietary genome editing platform, “ARCUS.” Precision leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and create healthy and sustainable food and agriculture solutions. Precision is actively developing product candidates in three innovative areas: allogeneic CAR T immunotherapy, in vivo gene correction, and food.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Immunotherapy Cancer Treatment Virotherapy Human Diseases Genome Genome Editing

    Is DTIL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 1 Precision BioSciences joins Russell Microcap Index
    Jun 27 Precision BioSciences Announces Presentation at UMDF Mitochondrial Medicine 2024 Supporting Advancement of PBGENE-PMM Program Towards IND and/or CTA in 2025
    Jun 20 Precision BioSciences Expands Hepatitis Scientific Advisory Board with Addition of World-Class Clinical Investigators Mark Sulkowski, M.D. and Jordan Feld, M.D., MPH, as PBGENE-HBV Program Nears Clinical Readiness
    Jun 5 Precision BioSciences Presents New Preclinical Safety Data for PBGENE-HBV Clinical Candidate at the European Association for the Study of the Liver Congress
    May 30 Precision BioSciences to Participate in Upcoming June Investor Conferences
    May 29 Does Precision BioSciences (DTIL) Have the Potential to Rally 200.55% as Wall Street Analysts Expect?
    May 17 Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
    May 16 Deep Dive Into Precision BioSciences Stock: Analyst Perspectives (4 Ratings)
    May 13 Precision BioSciences GAAP EPS of $1.70, revenue of $17.58M beats by $11.56M
    May 13 Precision BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
    See more DTIL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 21.9
    52 Week Low 8.25
    Average Volume 44,736
    200-Day Moving Average 11.59
    50-Day Moving Average 11.20
    20-Day Moving Average 11.02
    10-Day Moving Average 9.79
    Average True Range 0.62
    RSI (14) 35.90
    ADX 34.09
    +DI 11.85
    -DI 30.04
    Chandelier Exit (Long, 3 ATRs) 11.45
    Chandelier Exit (Short, 3 ATRs) 11.04
    Upper Bollinger Bands 13.73
    Lower Bollinger Band 8.31
    Percent B (%b) 0.29
    BandWidth 49.19
    MACD Line -0.69
    MACD Signal Line -0.55
    MACD Histogram -0.1336
    Fundamentals Value
    Market Cap 1.21 Billion
    Num Shares 122 Million
    EPS -0.86
    Price-to-Earnings (P/E) Ratio -11.50
    Price-to-Sales 0.94
    Price-to-Book 1.60
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 10.46
    Resistance 3 (R3) 10.43 10.20 10.36
    Resistance 2 (R2) 10.20 10.06 10.22 10.33
    Resistance 1 (R1) 10.05 9.97 10.12 10.08 10.30
    Pivot Point 9.82 9.82 9.86 9.84 9.82
    Support 1 (S1) 9.67 9.68 9.75 9.70 9.48
    Support 2 (S2) 9.44 9.59 9.46 9.45
    Support 3 (S3) 9.29 9.44 9.42
    Support 4 (S4) 9.32